suggests

Beyond Weight Loss and Blood Sugar: New NIH-Funded Research Suggests Semaglutide May Target the Fundamental Biology of Aging

The therapeutic landscape surrounding semaglutide—the active pharmacological agent underpinning widely prescribed glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic and…